menu
    • menu

    Company profile for Compass Therapeutics

    NEW Drugs in Dev: 7
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Compass Therapeutics is a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and multispecific antibody therapeutics. Compass is leveraging its proprietary StitchMabsTM and common light-chain based multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. The comp...
    Compass Therapeutics is a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and multispecific antibody therapeutics. Compass is leveraging its proprietary StitchMabsTM and common light-chain based multispecific platforms to empirically identify multispecifics and combinations of antibody therapeutics that synergistically modulate key nodes in the immune system. The company’s lead product candidate,

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Compass TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    245 First Street, 3rd Floor Cambridge, MA 02142
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.compasstherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/6406601/?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A6406601%2Cidx%3A2-1-2%2CtarId%3A1482960032803%2Ctas%3Acompass%20therap.
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Compass Therapeutics Joins May Investor Conference
    Compass Therapeutics Joins May Investor Conference

    12 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/12/3292725/0/en/compass-therapeutics-to-participate-in-upcoming-may-investor-events.html

    GLOBENEWSWIRE
    12 May 2026
    Share Share
    Compass Therapeutics Reports Q1 2026 Results & Update
    Compass Therapeutics Reports Q1 2026 Results & Update

    05 May 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7271640

    FIRSTWORD PHARMA
    05 May 2026
    Share Share
    Tovecimig Shows Benefits in Phase 2/3 Biliary Cancer Trial
    Tovecimig Shows Benefits in Phase 2/3 Biliary Cancer Trial

    27 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/27/3281512/0/en/tovecimig-demonstrates-statistically-significant-benefit-in-companion-002-randomized-phase-2-3-study-in-patients-with-biliary-tract-cancer.html

    GLOBENEWSWIRE
    27 Apr 2026
    Share Share
    Compass Therapeutics Reveals Key Results In Biliary Tract Cancer
    Compass Therapeutics Reveals Key Results In Biliary Tract Cancer

    27 Apr 2026

    // ENDPOINTS

    https://endpoints.news/compass-therapeutics-unveils-key-secondary-endpoint-results-from-pivotal-biliary-tract-cancer-trial/

    ENDPOINTS
    27 Apr 2026
    Share Share
    Compass Therapeutics To Release Phase 2/3 Tovecimig Study
    Compass Therapeutics To Release Phase 2/3 Tovecimig Study

    24 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/24/3281064/0/en/compass-therapeutics-to-announce-topline-secondary-endpoints-from-the-phase-2-3-companion-002-study-of-tovecimig-in-patients-with-biliary-tract-cancer.html

    GLOBENEWSWIRE
    24 Apr 2026
    Share Share
    Compass Therapeutics Reveals 2025 Financials And Corporate Update
    Compass Therapeutics Reveals 2025 Financials And Corporate Update

    05 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/05/3250042/0/en/Compass-Therapeutics-Reports-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    05 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search